A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver

Burns

Volumn 26, Issue 2, 2000, Pages 131-138

  Klasen, H J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CERIUM NITRATE; MAFENIDE; MAFENIDE ACETATE; SILVER; SILVER NITRATE; SULFADIAZINE SILVER;

ANTIBACTERIAL ACTIVITY; BURN; DRUG SOLUTION; ELECTRIC CURRENT; ESCHERICHIA COLI; HEMOLYTIC STREPTOCOCCUS; HUMAN; MARKET; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS;

EID: 0033971896     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(99)00116-3     Document Type: Short Survey

References (72)

1. Klasen HJ. A historical review of the use of silver in the treatment of burns. I. Early uses. Burns.
2. Moyer CA, Brentano L, Gravens DL, Margraf HW, Monafo WW. Treatment of large human burns with 0.5% silver nitrate solution. Arch Surg 1965;90:812-67.
3. Monafo WW. Carl Alfred Moyer 1902-1970. J Trauma 1971;11:900-5.
4. Bader KF. Organ deposition of silver following silver nitrate therapy of burns. Plast Reconstr Surg 1966;37:550-1.
5. Hartford CE. The bequests of Moncrief and Moyer: an appraisal of topical therapy of burns: 1981 American Burn Association Presidential address. J Trauma 1981;21:827-34.
6. Monafo WW, Moyer CA. The treatment of extensive thermal burns with 0.5% silver nitrate solution. Ann NY Acad Sci 1968;150:937-45.
7. Ziffren SE. Results of the treatment of burns with silver nitrate. Ann NY Acad Sci 1968;150:946-9.
8. Polk HC. Treatment of severe burns with aqueous silver nitrate (0.5%). Ann Surg 1966;164:753-70.
9. Wilde NJ. A comparison of silvernitrate treatment with other techniques in the treatment of burns. Plast Reconstr Surg 1967;40:271-6.
10. Lewis SR, Lynch JB, Blocker TG, Doyle JE, Larson DL. Evaluation of topical burn therapy over the past 20 years. In: Matter P, Barclay TL, Koníǩová Z, editors. Research in burns. Bern: Huber publishers, 1971. p. 111-6.
11. Lindberg RB, Moncrief JA, Switzer WE, Order SE, Mills W. The successful control of burn wound sepsis. J Trauma 1965;5:601-16.
12. Moncrief JA, Lindberg RB, Switzer WE, Pruitt BA. The use of a topical sulfonamide in the control of burn wound sepsis. J Trauma 1966;6:407-15.
13. Artz CP. Discussion. In: Polk HC, editor. Treatment of severe burns with aqueous silver nitrate (0.5%). Ann Surg 1966;164:769.
14. Fox CL. Silver sulphadiazine, addendum to local therapy. In: Modern treatment. New York: Hoeber Medical Division, Harper and Row, 1967. p. 1259.
15. Fox CL. Discussion. In: Stanford W, Rappole BW, Fox CL, editors. Clinical experience with silversulphadiazine. J. Trauma 1969;9:387-8.
16. Stanford W, Rappole BW, Fox CL. Clinical experience with silversulphadiazine. J Trauma 1969;9:377-88.
17. Fox CL, Stanford JW. Anti-bacterial action of silver sulphadiazine and DNA binding. In: Matter P, Barcaly TL, Koníǩová Z, editors. Research in burns. Bern: H. Huber publishers, 1971. p. 133-8.
18. Fox CL. Silver sulphadiazine: a new topical therapy for Pseudomonas in burns. Arch Surg 1968;96:184-8.
19. Skornik WA, Dressler DP. Topical antisepsis studies in the burned rat. Arch Surg 1971;103:469-74.
20. Snelling CFT, Roberts FJ, Germann E, Gillespie K, Coderre S, Henry D. Comparison of standard and chlorhexidine-derivate topical antibacterial agents on the infected burned rat wound. Burns 1988;14:91-100.
21. Eldad A, Neuman A, Weinberg A, Benmeir P, Rotem M, Wexler MR. Silversulfphadiazine-induced haemolytic anaemia in a glucose-6-phosphate dehydrogenase-deficient burn patient. Burns 1991;17:430-2.
22. Fox CL, Modak SA. Mechanism of silver sulphadiazine action on burn wound infections. Antimicrob Agents Chemother 1974;5:582-8.
23. van Saene JJM, Trooster JFG, Meulenhoff AMC, Lerk CF. Release and antimicrobial activity of silver sulphadiazine from different creams. Burns 1987;13:123-30.
24. Akahane T, Tsukada S. Electon-microscopic observation on silver disposition in burn wounds treated with silver sulphadiazine cream. Burns 1981;8:271-3.
25. Boosalis MG, McCall JT, Arhenholz DH, Solem LD. Serum and urinary silver levels in thermal injury patients. Surgery 1987;101:40-3.
26. Robb EC, Nathan P. Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulphadiazine) either from a cream base or from a solid synthetic dressing. J Trauma 1981;21:889-93.
27. Tsipouras N, Rix CJ, Brady PH. Solubility of silver sulphadiazine in physiological media and relevance to treatment of thermal burns with silver sulphadiazine cream. Clin Chem 1995;41:87-91.
28. Grossman AR. Silversulphadiazine cream in the management of burns. Am Fam Phys 1970;1:69-75.
29. Fuller FW, Engler PE. Leukopenia in non-septic burn patients receiving topical 1% silver sulphadiazine cream therapy: a survey. J Burn Care Rehabil 1988;9:606-9.
30. Jarrett F, Ellerbe S, Demling R. Acute leucopenia during topical burn therapy with silver sulphadiazine. Am J Surg 1978;135:818-9.
31. Smith-Choban P, Marshall WJ. Leukopenia secundary to silver sulphadiazine: frequency, characteristics and clinical consequences. Am Surg 1987;53:515-7.
32. Valente P, Axelrod JL. Acute leukopenia associated with silver sulphadiazine therapy. J Trauma 1978;18:146-7.
33. Gamelli RL, Paxton TP, O'Reilly M. Bone marrow toxicity by silver sulphadiazine. Surg Gynec Obstet 1993;177:115-20.
34. Fox CL, Rappole BW, Stanford W. Silversulphadiazine: an organic complex for topical chemotherapy of Pseudomonas infections in burns. In: Bertelli A, Donati L, editors. Pharmacological treatment of burns, proceedings of an international symposium, Milan, 1968. Amsterdam: Excerpta Medica, 1969. p. 224-33.
35. Fox CL, Rappole BW, Stanford W. Control of Pseudomonas infections in burns by silversulphadiazine. Surg Gynec Obstet 1969;96:1021-6.
36. Monafo WW, West MA. Current treatment recommendations for topical burn therapy. Drugs 1990;40:363-73.
37. Ollstein RN, MacDonald C. Topical and systemic antimicrobial agents in burns. Ann Plast Surg 1980;5:386-92.
38. Hoffmann S. Silver sulphadiazine: an antibacterial agent for topical use in burns. Scand J Plast Reconstr Surg 1984;18:119-26.
39. Hummel RP, MacMillan BG, Altemeier WA. Topical and systemic antibacterial agents in treatment of burns. Ann Surg 1970;172:370-84.
40. Feller J, Flora JD, Bawol R. Baseline results of therapy for burned patients. JAMA 1976;236:1943-7.
41. Pegg SP, Ramsay K, Meldrum L, Laundy M. Clinical comparison of maphenide and silver sulphadiazine. Scand J Plast Reconstr Surg 1979;13:95-101.
42. Lowbury EJL, Jackson DM, Ricketts CR, Davis B. Topical chemoprophylaxis for burns: trials of creams containing silver sulphadiazine and trimethoprim. Injury 1971;3:18-24.
43. Heggers JP, Robson MC. The emergence of silver sulphadiazine resistant Pseudomonas aeruginosa. Burns 1978;5:184-7.
44. Modak SM, Fox CL. Synergistic action of silver sulphadiazine and sodium piperacillin on resistent Pseudomonas aeruginosa in vitro in experimental burn wound infections. J Trauma 1985;25:27-31.
45. Lowbury EJL, Jackson DM, Lilly HA, Bull JP, Cason JS, Davies JWL, Ford PM. Alternative forms of local treatment for burns. Lancet 1971;2:1105-11.
46. Snelling CFT, Ronald AR, Waters WR, Yaworski DS, Drulak K, Sunderland M. Comparison of silver sulphadiazine and gentamycin for topical prophylaxis against burn wound sepsis. Can Med Assoc J 1978;119:466-70.
47. Dickinson SJ. Topical therapy of burns in children with silver sulphadiazine. NY State J Med 1973;73:2045-9.
48. Sawhney CP, Sharma RK, Rao KR, Kaushish R. Long-term experience with 1 per cent topical silver sulphadiazine cream in the management of burn wounds. Burns 1989;15:403-6.
49. Stern HS. Silver sulphadiazine and the healing of partial thickness burns: a prospective clinical trial. Br J Plast Surg 1989;42:581-5.
50. Monafo WW, Ayvazian VH, Skinner AM. Control of infection in major burn wounds by cerium nitrate/silver sulphadiazine. Burns 1976;3:104-7.
51. Rosenkranz HS. A synergistic effect between cerium nitrate and silver sulphadiazine. Burns 1978;5:278-81.
52. Holder JA. In vitro inactivation of silver sulphadiazine by the addition of cerium salts. Burns 1981;8:274-7.
53. Saffer LD, Rodeheaver GT, Hiebert JM, Edlich RF. In vivo and in vitro antimicrobial activity of silver sulphadiazine and cerium nitrate. Surg Gyn Obstet 1980;151:232-6.
54. Munster AM, Helvig E, Rowland S. Cerium nitrate/silver sulphadiazine cream in the treatment of burns: a prospective evaluation. Surgery 1980;88:658-60.
55. Peterson VM, Hansbrough JF, Wang XW, Zapata-Sirvent R, Boswick JA. Topical cerium nitrate prevents postburn immunosuppresion. J Trauma 1985;25:1039-44.
56. Boeckx W, Focquet M, Cornelissen M, Nuttin B. Bacteriological effect of cerium-flamazine cream in major burns. Burns 1985;11:337-42.
57. Ross DA, Phipps AJ, Clarke JA. The use of cerium nitrate-silver sulphadiazine as a topical burns dressing. Br J Plast Surg 1993;46:582-4.
58. Wassermann D, Schlotterer M, Lebreton F, Levy J, Guelfi MC. Use of topically applied silver sulphadiazine plus cerium nitrate in major burns. Burns 1989;15:257-60.
59. Boeckx W, Blondeel PhN, Vandersteen K, De Wolf-Peeters C, Schmitz A. Effect of cerium nitrate-silversulphadiazine on deep dermal burns: a histological hypothesis. Burns 1992;18:456-62.
60. Butcher HR, Margraf HW, Gravens DL. The treatment of large cutaneous burns with silver creams. J Trauma 1969;9:359-76.
61. Modak SM, Fox CL. Sulphadiazine silver-resistant Pseudomonas in burns. Arch Surg 1981;116:854-7.
62. Modak S, Stanford J, Friedlaender J, Fox P, Fox CL. Control of burn wound infections by penfloxacin and its silver derivative. Burns 1983;10:170-8.
63. Deitch EA, Sittig K, Heimbach D, Jordan M, Cruse W, Kahn A, Achauer B, Matsuda T, Salisbury R, Mani M, Saffe J. Results of a multicenter outpatient burn study on the safety and efficacy of Dimac-SSD a new delivery system for silver sulphadiazine. J Trauma 1989;29:430-4.
64. Deitch EA, Marino AA, Gillespie TE. Silver nylon: a new antimicrobial agent. Antimicrob Agents Chemother 1983;23:356-9.
65. Deitch EA, Marino AA, Malakanok V, Albright JA. Silver nylon cloth: in vitro and in vivo evaluation of antimicrobial activity. J Trauma 1987;27:301-4.
66. Chu CS, McManus AT, Pruitt BA, Mason AD. Therapeutic effects of silver nylon dressings with weak direct current on Pseudomonas aeruginosa-infected burn wounds. J Trauma 1988;28:1488-92.
67. Schmalzel JL, Chu CC, McManus AT. Constant-current and constant-voltage stimulators for wound healing studies. In: Proceedings of the eighth annual conference of the IEEE Engineering in Medicine and Biology Society, 1986, New York, 1986. p. 1482-4.
68. Chu CS, McManus AT, Mason AD, Okerberg CV, Pruitt BA. Multiple graft harvestings from deep partial-thickness scald wounds healing under the influence of weak direct current. J Trauma 1990;30:1044-50.
69. Chu CS, McManus AT, Okerberg CV, Mason AD, Pruitt BA. Weak direct current accelerates split-thickness graft healing on tangentially excised second-degree burns. J Burn Care Rehabil 1991;12:285-93.
70. Chu CS, Matylevich NP, McManus AT, Pruitt BA, Goodwin CW. Optimized mesh expansion of composite skin grafts in rats treated with direct current. J Trauma 1997;73:804-12.
71. Brown WS. Skin grafting. Boston Med J 1879;101:829-33.
72. Fakhry SM, Alexander J, Smith D, Meyer AA, Petterson HD. Regional and institutional variation in burn care. J Burn Care Rehabil 1995;16:86-90.